These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 26058345)

  • 21. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.
    Castañeda S; González-Juanatey C; González-Gay MA
    Clin Rev Allergy Immunol; 2019 Jun; 56(3):278-292. PubMed ID: 28852999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.
    Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindström U; Askling J; Jacobsson LTH
    Arthritis Res Ther; 2017 May; 19(1):102. PubMed ID: 28521824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up.
    Polo Y la Borda J; Castañeda S; Sánchez-Alonso F; Plaza Z; García-Gómez C; Ferraz-Amaro I; Erausquin C; Valls-García R; Fábregas MD; Delgado-Frías E; Mas AJ; González-Juanatey C; Llorca J; González-Gay MA;
    Semin Arthritis Rheum; 2024 Jun; 66():152442. PubMed ID: 38555727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of renal dysfunction in patients with inflammatory arthropathies: strong association with cardiovascular diseases and not with anti-rheumatic therapies, inflammatory markers or duration of arthritis.
    Haroon M; Adeeb F; Devlin J; O Gradaigh D; Walker F
    Int J Rheum Dis; 2011 Aug; 14(3):255-60. PubMed ID: 21816021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular disease and rheumatoid arthritis: an update.
    Charles-Schoeman C
    Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.
    Gossec L; Salejan F; Nataf H; Nguyen M; Gaud-Listrat V; Hudry C; Breuillard P; Dernis E; Boumier P; Durandin-Truffinet M; Fannius J; Fechtenbaum J; Izou-Fouillot MA; Labatide-Alanore S; Lebrun A; LeDevic P; LeGoux P; Sacchi A; Salliot C; Sparsa L; d'André FL; Dougados M;
    Arthritis Care Res (Hoboken); 2013 May; 65(5):712-7. PubMed ID: 23589412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
    Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study.
    Fernández-Carballido C; Martín-Martínez MA; García-Gómez C; Castañeda S; González-Juanatey C; Sánchez-Alonso F; García de Vicuña R; Erausquin-Arruabarrena C; López-Longo J; Sánchez MD; Corrales A; Quesada-Masachs E; Chamizo E; Barbadillo C; Bachiller-Corral J; Cobo-Ibañez T; Turrión A; Giner E; Llorca J; González-Gay MA;
    Arthritis Care Res (Hoboken); 2020 Jun; 72(6):822-828. PubMed ID: 31033231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome.
    Cioffi G; Viapiana O; Tarantini L; Orsolini G; Idolazzi L; Sonographer FO; Dalbeni A; Gatti D; Fassio A; Rossini M; Giollo A
    Intern Emerg Med; 2021 Jun; 16(4):863-874. PubMed ID: 33083946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden.
    Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
    Arthritis Rheumatol; 2014 May; 66(5):1282-90. PubMed ID: 24782185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L; Pope JE; Payne M
    J Rheumatol; 2009 Jul; 36(7):1421-8. PubMed ID: 19487267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
    Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
    Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
    Ajeganova S; Andersson ML; Frostegård J; Hafström I
    J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.
    Emanuel G; Charlton J; Ashworth M; Gulliford MC; Dregan A
    Heart; 2016 Dec; 102(24):1957-1962. PubMed ID: 27534979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.